Tax planning for practice-owning dentists

Dentists are business owners first, clinicians second. Here’s the entity structure and tax stack for dental practice owners.

Most of us went into dentistry to be clinicians. We spent years mastering the technical skills of our craft. But the day you sign the paperwork to open your own practice, your job description changes. You’re no longer just a dentist; you’re the CEO, CFO, and COO of a complex small business. The clinical work is the product, but the business is what determines your financial success and professional freedom.

Managing the business side, particularly the tax implications, is often where clinicians feel least comfortable. Yet, strategic tax planning can have a greater impact on your net worth than seeing a few extra patients a week. It’s the difference between building substantial wealth and feeling like you’re on a high-income treadmill. This isn’t about finding sketchy loopholes; it’s about understanding the tax code as a set of incentives and aligning your practice operations to leverage them legally and effectively. For a deeper dive into financial tools and resources, see the full dentistry free tools hub.

Private Equity Buyout Tax Structuring: Asset Sale vs. Stock Sale

The dental industry is a prime target for private equity (PE) roll-ups. If you own a successful practice, it’s not a question of *if* you’ll get a call from a potential buyer, but *when*. The headline number on the letter of intent (LOI) is exciting, but it’s the deal structure that dictates how much of that money you actually keep.

When you sell your practice, the deal will almost always be structured as either an asset sale or a stock sale.

• Asset Sale: The buyer purchases the individual assets of your practice—equipment, patient lists, accounts receivable, and goodwill. The buyer loves this because they get a “stepped-up basis” in the assets, allowing them to depreciate the equipment from its new, higher value, creating immediate tax deductions for them. For you, the seller, this is often a tax nightmare. The proceeds allocated to depreciated equipment and accounts receivable are taxed as ordinary income, which can be nearly double the capital gains rate.
• Stock Sale: The buyer purchases the stock (or membership interest) of your S-Corp or LLC. The entire business, including all its assets and liabilities, transfers to the new owner. As the seller, this is usually the ideal structure. The sale of your stock qualifies for long-term capital gains treatment (assuming you’ve held it for more than a year), resulting in a significantly lower tax bill.

The Planning Trap: Most dentists focus solely on the purchase price. A $5 million asset sale could easily leave you with less after-tax cash than a $4.5 million stock sale. The negotiation over deal structure is a multi-hundred-thousand-dollar conversation disguised as legal boilerplate. Don’t let the buyer’s preference for an asset sale dictate your financial outcome without a corresponding increase in the purchase price to make you whole on a post-tax basis.

The How-To: Before you even entertain an LOI, engage an M&A attorney and a CPA who specialize in dental practice transitions. Model the after-tax proceeds of both an asset and a stock sale. If a buyer insists on an asset sale, your team can negotiate the allocation of the purchase price among different asset classes to minimize the ordinary income component and push more value toward goodwill, which is taxed at capital gains rates.

The Mechanics of an Equity Rollover Deal

In many PE deals, the offer isn’t all cash. A common structure involves the practice owner receiving a large portion in cash and “rolling over” the rest into equity in the new, larger parent company (the “NewCo”). This can be a powerful tax-deferral tool, but it comes with its own set of risks.

Here’s how it works: Let’s say your practice is valued at $4 million. The PE firm offers you $2.8 million in cash (70%) and $1.2 million in NewCo equity (30%).

The Tax Benefit: Under IRS rules (like §351 or §721, depending on the entity structure), the equity rollover portion is a tax-deferred event. You only pay capital gains tax on the $2.8 million cash you receive in the year of the sale. The $1.2 million in equity retains its cost basis, and you won’t owe any tax on it until a “second liquidity event”—for example, when the PE firm sells the entire platform to another, larger buyer five to seven years down the road.

This allows you to defer a significant tax liability and participate in the potential upside as the PE firm grows the larger entity. If they successfully execute their strategy, your $1.2 million rollover could be worth two or three times that at the next sale.

The Planning Trap: Concentration risk. You are trading 100% ownership of a business you control for a small, illiquid, minority stake in a business you don’t. If the PE firm’s strategy fails or the market turns, that rollover equity could become worthless. Most of us learned the hard way in our training that you never want to be the one holding the bag without having a say in the decisions. The same applies here. You’ve taken a huge amount of risk off the table with the cash portion, but the rollover piece is still very much at risk.

The How-To:

1. Diligence the Buyer: Investigate the PE firm’s track record. Have their other dental platforms been successful? Talk to other dentists who have sold to them.
2. Negotiate Equity Terms: Understand what you’re getting. Is it preferred equity with a liquidation preference, or common equity that’s first to get wiped out? What are your rights as a minority shareholder?
3. Balance Your Risk: Decide on a rollover percentage that aligns with your risk tolerance. A higher rollover means more potential upside and greater tax deferral, but also more risk. A lower rollover locks in your gains but limits future growth. There is no single right answer, but you must make the decision consciously.

Unlocking R&D Tax Credits for Your Practice

When dentists hear “Research and Development (R&D) tax credit,” they typically think of software companies or biotech labs. Most are completely unaware that their own clinical activities can qualify, leaving tens of thousands of dollars on the table each year.

The R&D tax credit, governed by IRC §41, is designed to incentivize businesses to invest in improving products and processes. For a dental practice, this isn’t about discovering a new element; it’s about the systematic process of experimentation to solve a technical challenge.

Qualifying Activities in Dentistry:

• Custom Appliances: Developing or refining a process for creating custom surgical guides, clear aligners, or sleep apnea devices. If you are using 3D printing and CAD/CAM software to test different designs or materials to achieve a better clinical outcome, the staff time and material costs can qualify.
• New Clinical Techniques: Experimenting with new implant placement protocols, grafting materials, or restorative procedures. The key is documenting the process of evaluation—what was the technical uncertainty you were trying to overcome?
• Internal Software Development: Building or significantly customizing your practice management or patient communication software. If you’re paying developers to create a unique workflow that improves efficiency, those costs often qualify.

The Planning Trap: Lack of documentation. The IRS requires you to prove that you undertook a systematic process of experimentation. You can’t simply claim the credit retroactively without records. Most practices fail to claim the credit because their bookkeepers aren’t trained to identify and track these “qualified research expenses” (QREs) separately from general operating costs.

The How-To:

1. Identify Potential Projects: At the beginning of the year, list any new techniques, materials, or processes you plan to evaluate.
2. Track Your Time and Expenses: Create a system (even a simple spreadsheet) to log the hours your staff (including yourself) spends on these projects and the cost of any supplies consumed.
3. Document the Process: For each project, write a short summary of the technical problem, the alternatives you considered and tested, and the final outcome.
4. Engage a Specialist: The calculation for the R&D credit (Form 6765) is complex. Work with a specialized tax firm that has experience with R&D credits for medical and dental practices. They can conduct a study to identify all qualifying expenses and prepare the necessary documentation to support the claim.

Practice Valuation: The EBITDA Multiples That Drive Your Exit

Whether you’re planning to sell to PE, an associate, or another dentist, your practice’s value will be determined by a simple formula: EBITDA x Multiple.

EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. It’s a proxy for the practice’s operating cash flow. To calculate it, you start with your net income and add back those non-cash or non-operating expenses. Critically, you also add back “owner add-backs”—personal expenses run through the business (like your car lease), excess owner salary, and other benefits that a new owner wouldn’t have to pay.

While maximizing EBITDA is crucial, the real leverage comes from increasing the *multiple*. A practice with $500,000 in EBITDA might sell for 5x ($2.5 million) or 8x ($4.0 million). The difference lies in the quality and predictability of those earnings.

Key Drivers That Increase Your Multiple:

• Recurring Revenue: A practice with a robust in-house membership plan for hygiene and preventative care is far more valuable than one reliant on one-off, high-cost procedures. Buyers pay a premium for predictable revenue.
• Low Owner-Dependence: If you are the only provider and all the patients are loyal to you personally, the practice has high “key-person risk.” A practice with multiple associate dentists and a strong brand independent of any single provider will command a higher multiple.
• Modern Infrastructure: Up-to-date operatories, digital imaging (CBCT), and modern practice management software signal to a buyer that they won’t need to make a large capital investment immediately after purchase.
• Favorable Payer Mix: A strong fee-for-service base or favorable contracts with PPOs is more attractive than heavy reliance on low-reimbursement DMOs or Medicaid.
• Geographic Concentration: For a PE roll-up, a practice with several locations in a desirable metro area is more valuable than a single rural office because it provides an immediate platform for growth.

The Planning Trap: Focusing on top-line revenue instead of bottom-line profitability. I’ve seen practices that generate $3 million in collections but have such high overhead that their EBITDA is lower than a well-run $1.5 million practice. Buyers buy cash flow, not revenue. A high EBITDA *margin* is the ultimate sign of an efficient, well-managed business.

Getting your books in order and understanding these metrics requires professional help. This is not a DIY project. Finding a physician-focused CPA who handles dental practices is the first step in preparing for a successful exit, even if that exit is years away.

Supercharging Depreciation with Cost Segregation Studies

If you own the building that houses your dental practice, you are likely sitting on one of the most powerful tax-deferral strategies available: the cost segregation study.

When you purchase a commercial property, the IRS typically requires you to depreciate the value of the building over a 39-year straight-line schedule. This results in a relatively small annual deduction. A cost segregation study is an engineering-based analysis that dissects the components of your building and reclassifies them into shorter-lived asset classes.

Instead of treating the entire building as one 39-year asset, the study identifies components that can be depreciated over 5, 7, or 15 years.

• 5-Year Property: Carpeting, cabinetry, specialty electrical and plumbing for dental equipment, decorative lighting.
• 7-Year Property: Office furniture.
• 15-Year Property: Land improvements like parking lots, sidewalks, and landscaping.

By reclassifying, say, 25% of a $1 million building’s cost from 39-year property to 5-year property, you can accelerate $250,000 of depreciation deductions into the first five years of ownership. When combined with “bonus depreciation” (which under current law allows you to deduct a large percentage of the cost of short-lived property in the first year), the result can be a massive paper loss in year one.

The Planning Trap: Believing this is only for new construction. You can perform a cost segregation study on a property you purchased years ago and take a “catch-up” depreciation deduction (a §481(a) adjustment) in the current year for all the depreciation you missed. This can create a huge one-time tax refund.

The How-To:

1. Engage a Reputable Firm: This is not a job for your regular CPA. You need to hire a specialized engineering firm that performs these studies. They will conduct a site visit, review architectural drawings, and provide a detailed report that will stand up to IRS scrutiny.
2. Analyze the Timing: The ideal time to do a study is in the year you purchase or construct the building to maximize the benefit of bonus depreciation.
3. Pair with REPS: For maximum impact, this strategy is often paired with Real Estate Professional Status (REPS). If your spouse qualifies for REPS, the large paper losses generated by the cost segregation study are not “passive” and can be used to offset your active clinical income, potentially wiping out your entire income tax liability for the year.

The strategies that move the needle in your financial life as a practice owner are rarely clinical. They live in the tax code and on the balance sheet. Mastering these concepts—from structuring your eventual exit to optimizing your real estate—is what separates a high-income job from true wealth creation. It requires a shift in mindset, from clinician to CEO, and a commitment to building a team of advisors who can execute on your behalf.

Reviewed by Pouyan Golshani, MD, Interventional Radiologist — May 7, 2026